MedTrace Logo

A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy

NCT02619656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2015-12-02

No results posted yet for this study

Summary

The investigators hypothesize that using carbon dioxide for PEG placement versus using room air will decrease post-procedure pneumoperitoneum as well as improve post-procedure bloating/pain, and waist circumference.

Conditions

  • Pneumoperitoneum

Interventions

PROCEDURE

CO2 insufflation

Patients were randomized to insufflation with CO2.

PROCEDURE

Ambient air insufflation

Patients were randomized to insufflation with ambient air.

Sponsors & Collaborators

Principal Investigators

  • Christopher Murphy, MD · University of Utah SOM

  • John C Fang, MD · University of Utah SOM

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619656 on ClinicalTrials.gov